Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125489182 | 12548918 | 2 | F | 20160609 | 20160813 | 20160712 | 20160818 | PER | US-MEDA-2016070034 | MEDA | 84.00 | YR | E | M | Y | 69.00000 | KG | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125489182 | 12548918 | 1 | PS | TORSEMIDE. | TORSEMIDE | 1 | Oral | Y | 20136 | 100 | MG | ||||||||
| 125489182 | 12548918 | 2 | SS | TORSEMIDE. | TORSEMIDE | 1 | Oral | Y | 20136 | 160 | MG | ||||||||
| 125489182 | 12548918 | 3 | SS | TAFAMIDIS MEGLUMINE;PLACEBO | TAFAMIDIS MEGLUMINE | 1 | Oral | 0 | MG | CAPSULES | QD | ||||||||
| 125489182 | 12548918 | 4 | SS | TAFAMIDIS MEGLUMINE;PLACEBO | TAFAMIDIS MEGLUMINE | 1 | Oral | 0 | CAPSULES | ||||||||||
| 125489182 | 12548918 | 5 | C | ALENDRONATE | ALENDRONATE SODIUM | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 6 | C | BISACODYL. | BISACODYL | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 7 | C | CALCIUM | CALCIUM | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 8 | C | CHOLECALCIFEROL | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 9 | C | ECOTRIN | ASPIRIN | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 10 | C | FISH OIL | FISH OIL | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 11 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 12 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 13 | C | SULFACETAMIDE SODIUM CLEANSER | 2 | 0 | |||||||||||||
| 125489182 | 12548918 | 14 | C | TAMSULOSIN | TAMSULOSIN | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 15 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 16 | C | WARFARIN | WARFARIN | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 17 | C | ALBUTEROL. | ALBUTEROL | 1 | 0 | ||||||||||||
| 125489182 | 12548918 | 18 | C | LASIX | FUROSEMIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125489182 | 12548918 | 1 | Diuretic therapy |
| 125489182 | 12548918 | 2 | Diuretic therapy |
| 125489182 | 12548918 | 3 | Cardiomyopathy |
| 125489182 | 12548918 | 4 | Cardiomyopathy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125489182 | 12548918 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125489182 | 12548918 | Hypovolaemia | |
| 125489182 | 12548918 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125489182 | 12548918 | 1 | 20160607 | 20160608 | 0 | |
| 125489182 | 12548918 | 2 | 20160609 | 20160609 | 0 | |
| 125489182 | 12548918 | 3 | 20150520 | 20160610 | 0 | |
| 125489182 | 12548918 | 5 | 20130315 | 0 | ||
| 125489182 | 12548918 | 6 | 20150306 | 0 | ||
| 125489182 | 12548918 | 7 | 20000715 | 0 | ||
| 125489182 | 12548918 | 8 | 20110212 | 0 | ||
| 125489182 | 12548918 | 9 | 20050522 | 0 | ||
| 125489182 | 12548918 | 10 | 20050222 | 0 | ||
| 125489182 | 12548918 | 11 | 20111022 | 0 | ||
| 125489182 | 12548918 | 12 | 20050522 | 0 | ||
| 125489182 | 12548918 | 13 | 20000123 | 0 | ||
| 125489182 | 12548918 | 14 | 20120408 | 0 | ||
| 125489182 | 12548918 | 16 | 20150818 | 0 | ||
| 125489182 | 12548918 | 17 | 20150724 | 0 | ||
| 125489182 | 12548918 | 18 | 20160606 | 0 |